13F Holdings
中文EN

QTRX Quanterix Corp

Laboratory Analytical Instruments · Nasdaq · SEC CIK 1503274 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY13.8%
TTM net income YoY-16.2%
TTM EPS YoY0.0%
Revenue 3-yr CAGR8.3%
Net income 3-yr CAGR—

Margins

Gross margin41.7%
Operating margin-93.2%
Net margin-75.0%
FCF margin-37.8%
EBITDA margin-76.7%

Returns

ROE-41.7%
ROA-29.9%
ROIC (approx.)-47.4%
Asset turnover0.40x

Leverage & solvency

Liabilities / assets27.0%
Debt / equity0.00x
Current ratio3.09x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.50x
Accruals ratio-14.9%
Payout ratio—
Capex / revenue0.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$138.90M$137.42M$122.37M$105.52M$110.56M
Cost of revenue$73.94M$54.32M$48.14M$60.16M$45.78M
Gross profit$64.96M$83.10M$74.22M$45.36M$64.77M
R&D expense$35.92M$31.08M$26.06M$26.81M$28.38M
SG&A expense$138.01M$101.62M$89.11M$91.85M$92.91M
Operating income-$125.54M-$52.62M-$45.99M-$104.26M-$56.52M
Pretax income-$112.27M-$38.10M-$27.64M-$99.41M-$55.58M
Income tax-$5.12M$434,000$719,000$164,000-$36,000
Net income-$107.15M-$38.53M-$28.35M-$99.57M-$55.55M
EBITDA-$109.70M-$46.15M-$39.72M-$98.86M-$51.64M
EPS (basic)-2.51-1.00-0.75-2.69-1.54
EPS (diluted)-2.51-1.00-0.75-2.69-1.54
Weighted avg. shares (diluted)42.64M38.37M37.59M36.99M36.00M
Banking
Net interest income$8.57M$14.65M$15.84M$5.13M-$403,000
Provision for credit losses$1.47M$712,000$729,000$752,000$213,000
Balance sheet
Cash & equivalents$29.84M$59.32M$177.03M$341.34M$399.27M
Short-term investments$88.39M$232.41M$6.89M$0—
Receivables$29.97M$32.14M$25.41M$19.02M$23.79M
Inventory$54.76M$32.77M$26.12M$16.96M$22.19M
Current assets$212.26M$363.59M$382.10M$381.52M$448.95M
PP&E, net$23.67M$17.15M$17.93M$19.81M$17.96M
Goodwill$26.38M$0$0$0$9.63M
Intangibles$131.79M$4.03M$6.03M$7.52M$10.53M
Total assets$418.77M$406.53M$428.57M$433.58M$501.53M
Current liabilities$74.76M$42.01M$38.98M$31.35M$36.98M
Total liabilities$123.04M$76.50M$78.61M$75.65M$60.58M
Shareholders' equity$295.73M$330.04M$349.96M$357.93M$442.79M
Shares outstanding46.74M38.57M38.01M37.28M36.77M
Cash flow statement
Operating cash flow-$77.24M-$35.16M-$18.85M-$48.61M-$47.62M
Capital expenditure$2.61M$3.37M$3.84M$11.61M$13.68M
Free cash flow-$79.85M-$38.53M-$22.69M-$60.23M-$61.30M
Investing cash flow$50.23M-$82.27M-$148.45M-$11.09M-$6.40M
Financing cash flow-$708,000$456,000$2.69M$2.31M$270.80M
Depreciation & amortization$15.84M$6.46M$6.28M$5.41M$4.88M
Stock-based compensation$20.72M$19.99M$16.82M$15.38M$15.97M

Free plan shows the latest 5 periods; Pro shows all 10 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.